Skip to content
Bending the Curve Trial by Trial
?

Second cancers among 40,576 testicular cancer patients: focus on long-term survivors

Phase observationalN = 40,576

Population
One-year survivors of testicular cancer in 14 population-based registries (2,285 second solid cancers)
Design
Pooled registry cohort of 1-year survivors of testicular cancer diagnosed 1943 to 2001 in 14 population-based registries in Europe and North America. Poisson regression modelled relative risks and excess absolute risks of second solid cancers.
Arms
  • General population (control): General-population reference rates (not a study arm)
  • Seminoma at age 35 (experimental): Men diagnosed with seminoma at age 35 years
  • Non-seminoma at age 35 (experimental): Men diagnosed with a nonseminomatous tumour at age 35 years
People
Travis LB
Δ 480-month Cumulative second solid cancer risk+13 points
Show the numbers
Results reported for Second cancers among 40,576 testicular cancer patients: focus on long-term survivors
EndpointAnalysisSeminoma at age 35 / Non-seminoma at age 35General populationEffect
Cumulative second solid cancer riskMen diagnosed at age 35 years; cumulative risk 40 years later (to age 75 years)finalTravis 200536% at 40 y23% at 40 yModel-based cumulative risk of a solid cancer for men diagnosed at age 35 years, 40 years later (to age 75 years), as stated in the abstract; no confidence intervals are given there. The 23% for the general population is a reference rate, not a trial arm.
Results reported for Second cancers among 40,576 testicular cancer patients: focus on long-term survivors
EndpointAnalysisSeminoma at age 35 / Non-seminoma at age 35General populationEffect
Cumulative second solid cancer riskMen diagnosed at age 35 years; cumulative risk 40 years later (to age 75 years)finalTravis 200536% at 40 y23% at 40 yModel-based cumulative risk of a solid cancer for men diagnosed at age 35 years, 40 years later (to age 75 years), as stated in the abstract; no confidence intervals are given there. The 23% for the general population is a reference rate, not a trial arm.
Primary publication: Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 2005;97(18):1354-65. PubMedDOI

Appears in

Sources

  1. Travis LB, Fosså SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H, et al. Second cancers among 40,576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst. 2005;97(18):1354-65.

    PubMedDOI